submacular hemorrhage: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by dreye

submacular hemorrhage Introduction (What it is)

submacular hemorrhage is bleeding that collects under the macula, the central area of the retina used for detailed vision.
It can cause sudden central blur, distortion, or a dark spot in the middle of vision.
In clinical care, it is a diagnosis and an exam finding that helps explain acute vision loss.
It is commonly discussed in retina clinics, emergency eye evaluations, and imaging reports (such as OCT).

Why submacular hemorrhage used (Purpose / benefits)

submacular hemorrhage is not a product or a procedure; it is a clinical term used to describe a specific location of retinal bleeding. Using this term precisely matters because the macula contains tightly packed photoreceptors responsible for reading, recognizing faces, and fine-detail tasks.

The “purpose” of identifying submacular hemorrhage is to:

Localize the problem: “Submacular” indicates the bleeding is affecting the macula rather than the peripheral retina, which often changes urgency, workup, and prognosis.
Guide the diagnostic workup: The pattern and location of blood can point clinicians toward likely causes (for example, abnormal blood vessel growth under the retina).
Support treatment planning: Many management decisions depend on the suspected underlying source of bleeding (such as choroidal neovascularization) and the appearance on imaging.
Track change over time: Documenting a submacular hemorrhage allows clinicians to monitor whether the hemorrhage is stable, resolving, or recurring.

In general terms, recognizing submacular hemorrhage helps clinicians address two related problems: the immediate effect of blood on the macula (which can reduce vision) and the underlying condition that caused the bleeding (which may continue to damage retinal tissue if active).

Indications (When ophthalmologists or optometrists use it)

Clinicians use the term submacular hemorrhage when documenting or discussing findings in situations such as:

Sudden onset central vision loss, distortion (metamorphopsia), or a central scotoma
Suspected or known age-related macular degeneration (AMD), especially “wet” (neovascular) AMD
Polypoidal choroidal vasculopathy (often considered within the pachychoroid spectrum in many clinical frameworks)
High myopia with suspected myopic choroidal neovascularization
Ocular trauma with subretinal bleeding involving the macula
Retinal arterial macroaneurysm or other retinal vascular abnormalities with macular involvement
Angioid streaks or other conditions associated with fragile Bruch’s membrane and secondary neovascularization
Pre- and post-treatment documentation in retina care (clinic notes, OCT interpretation, fundus photos)

Contraindications / when it’s NOT ideal

Because submacular hemorrhage is a diagnosis rather than a treatment, “contraindications” mainly apply to how the finding is interpreted and when certain intervention approaches may be less suitable. Situations where a different term, additional evaluation, or a different approach may be more appropriate include:

Bleeding is not under the macula: For example, subretinal hemorrhage outside the macula, preretinal hemorrhage, or vitreous hemorrhage may require different terminology and workup.
The view is obscured and the location is uncertain: Dense vitreous hemorrhage, corneal opacity, or cataract may limit certainty; imaging choices vary by clinician and case.
A masquerade diagnosis is possible: Some pigmented or reddish lesions can mimic hemorrhage; clinicians may use imaging to confirm.
Chronic, organized blood with advanced scarring: Some displacement-oriented interventions may be less effective when blood has been present longer and becomes more organized; this varies by clinician and case.
Patient-specific factors that affect procedural options: The suitability of injections, gas placement, or surgery depends on ocular anatomy, lens status, medical history, and ability to comply with positioning—details that vary by clinician and case.
Alternative primary problem is driving symptoms: For example, macular edema, macular hole, or central serous chorioretinopathy can cause central vision changes without hemorrhage.

How it works (Mechanism / physiology)

submacular hemorrhage reflects bleeding into the subretinal space (between the neurosensory retina and the retinal pigment epithelium, or RPE) or closely related compartments near the macula. Understanding the involved anatomy helps explain why it can affect vision quickly.

Relevant anatomy (plain-language overview)

Retina: The light-sensing tissue lining the back of the eye.
Macula: The central retina used for sharp, straight-ahead vision.
Fovea: The center of the macula with the highest visual resolution.
Photoreceptors: Cells (cones and rods) that convert light into signals.
RPE (retinal pigment epithelium): A support layer under the retina essential for photoreceptor health.
Bruch’s membrane and choroid: Layers beneath the RPE; the choroid is rich in blood vessels.

Physiologic impact (high level)

Blood under the macula can reduce vision through several overlapping mechanisms:

Physical separation: Blood can separate photoreceptors from the RPE, disrupting normal metabolic support.
Optical blockage: Blood can block or scatter light before it reaches photoreceptors.
Biochemical effects: Breakdown products of blood and iron-related toxicity are often discussed as potential contributors to tissue injury in subretinal hemorrhage.
Clot contraction and scarring: As blood organizes, it may contribute to structural damage and fibrosis, especially if an underlying neovascular process is active.

Onset, duration, and reversibility

Onset is often sudden, particularly when a fragile abnormal vessel leaks or ruptures.
Duration varies widely. Small hemorrhages may clear over time, while larger or thicker hemorrhages may persist or organize.
Reversibility is variable. Some people recover part of their vision, while others have lasting changes due to damage to photoreceptors, RPE disruption, or scar formation. Prognosis depends strongly on the cause, size/thickness, and the condition of the macula before the bleed.

submacular hemorrhage Procedure overview (How it’s applied)

submacular hemorrhage itself is not a procedure. Instead, it is a finding that triggers a structured evaluation and, in some cases, interventions aimed at (1) treating the underlying cause and (2) addressing the blood’s effect on the macula. A typical high-level workflow is:

Evaluation / exam – Symptom history (onset, distortion, central dark spot, trauma history) – Visual acuity testing and pupil exam – Dilated retinal examination to identify the location and extent of bleeding
Imaging and documentation – OCT (optical coherence tomography) to map retinal layers and confirm subretinal involvement – Color fundus photography for baseline documentation – Fluorescein angiography and/or indocyanine green angiography when clinicians need to evaluate abnormal vessels beneath the retina (used selectively; varies by clinician and case)
Determining the likely cause – Common causes include neovascular AMD and other sources of choroidal neovascularization, vascular anomalies, or trauma-related injury.
Intervention / testing (when selected) – Some cases are monitored, while others are treated with medication injections or surgical approaches. The choice depends on hemorrhage characteristics and the suspected source.
Immediate checks – Reassessment of vision, eye pressure, and symptoms after any in-office procedure – Review of warning signs that should prompt reassessment (general education rather than individualized instructions)
Follow-up – Repeat OCT and clinical exam to monitor resolution of blood and activity of the underlying disease – Longer-term monitoring for recurrence, scar formation, or complications related to the primary condition

Types / variations

submacular hemorrhage is often described using practical clinical descriptors rather than a single formal classification. Common variations include:

By cause (etiology)
Neovascular AMD-related submacular hemorrhage
Polypoidal choroidal vasculopathy–associated hemorrhage
Myopic choroidal neovascularization–associated hemorrhage
Trauma-related submacular hemorrhage (including choroidal rupture)
Retinal arterial macroaneurysm–related macular bleeding
Less common systemic or ocular conditions that predispose to bleeding (varies by clinician and case)
By location
Foveal-involving (directly affecting the center of the macula)
Extrafoveal submacular (near the macula but sparing the foveal center)
By size and thickness
Small/thin hemorrhage versus large/thick hemorrhage
Thickness is often inferred from OCT and clinical appearance; terminology can differ across clinicians and studies.
By timing
Acute (new onset)
Subacute/chronic (blood present longer and more organized)
By associated findings
Presence of subretinal fluid, pigment epithelial detachment, or visible neovascular membrane features on imaging
Coexisting vitreous hemorrhage or retinal tears in trauma or vascular cases

Pros and cons

Pros:

Helps pinpoint the anatomic site of bleeding responsible for central vision symptoms
Provides a shared term that supports clear communication across optometry, ophthalmology, and retina teams
Encourages macula-focused imaging (especially OCT) for detailed structural assessment
Often prompts a search for a treatable underlying cause (for example, active neovascularization)
Supports baseline documentation so change can be tracked over time
Helps set expectations that outcomes can be variable depending on the cause and macular health

Cons:

The term describes where the blood is, not why it happened, so additional evaluation is usually needed
Appearance can be difficult to interpret when media is cloudy (cataract, corneal disease, vitreous hemorrhage)
Prognosis is not uniform and can be hard to predict from symptoms alone
Management pathways differ across cases; there is no single “standard” approach that fits everyone
Some interventions considered for submacular blood may carry procedure-related risks (which vary by clinician and case)
Even if the blood clears, scarring or underlying disease activity may still limit vision recovery

Aftercare & longevity

“Aftercare” for submacular hemorrhage generally means ongoing monitoring of the macula and management of the underlying condition that caused the bleed. Because this is informational only, the specifics of follow-up timing and treatment schedules are intentionally not detailed and vary by clinician and case.

Factors that commonly influence outcomes and how long improvements last include:

Underlying diagnosis control
If abnormal vessel growth remains active, additional leakage or re-bleeding can occur.
Long-term disease behavior varies widely across conditions such as neovascular AMD, polypoidal disease, or myopic CNV.
Initial hemorrhage characteristics
Size, thickness, and whether the fovea is involved can affect visual recovery potential.
Associated retinal swelling or pigment epithelial detachment may also influence the course.
Baseline macular health
Prior macular degeneration, atrophy, or scarring can limit the degree of visual recovery even if the hemorrhage resolves.
Follow-up adherence and imaging
Repeat exams and OCT imaging help clinicians identify persistent fluid, scar development, or recurrence early.
Comorbid eye and health factors
Coexisting glaucoma, significant cataract, anticoagulant use, or systemic vascular disease may complicate the overall picture; the relevance varies by clinician and case.

Longevity of results is usually discussed in two parts: (1) whether the blood clears and vision stabilizes, and (2) whether the underlying disease stays quiet or reactivates over time.

Alternatives / comparisons

Because submacular hemorrhage is a condition rather than a treatment, “alternatives” typically mean different management strategies depending on the hemorrhage and its cause. Common comparisons include:

Observation / monitoring vs active intervention
Monitoring may be considered in smaller hemorrhages or when imaging suggests limited threat to the fovea, while other cases prompt active treatment. The balance depends on risk, cause, and clinician judgment.
Treating the underlying neovascular process vs focusing on the blood
In neovascular AMD and related conditions, therapies often target abnormal vessel activity (to reduce further leakage/bleeding).
Separate approaches may be considered to physically displace or clear submacular blood in select scenarios; suitability varies by clinician and case.
Office-based injection approaches vs operating room procedures
Some interventions can be performed in clinic settings, while others require surgery (for example, vitrectomy-based strategies). The decision depends on hemorrhage features, lens status, vitreous condition, and patient factors.
Laser- or light-based therapies in selected diagnoses
Certain underlying causes (such as particular vascular lesions) may be managed with focal treatments in some cases, while macular-involving bleeding often requires careful risk–benefit consideration. Exact indications vary by clinician and case.
Comparison with other “macular emergencies”
submacular hemorrhage is distinct from macular hole, retinal detachment involving the macula, or central retinal artery occlusion, which have different mechanisms and management pathways—even though symptoms can overlap.

submacular hemorrhage Common questions (FAQ)

Q: Is submacular hemorrhage the same as a retinal hemorrhage?
A: It is a type of retinal-related bleeding defined by its location under the macula. “Retinal hemorrhage” is broader and can refer to bleeding within different retinal layers or nearby spaces. The location matters because the macula is responsible for central detailed vision.

Q: Does submacular hemorrhage hurt?
A: Many people describe sudden visual changes without pain. The eye may feel normal even when central vision is significantly affected. Pain can suggest other eye problems, so clinicians typically consider the full symptom pattern.

Q: What are common causes of submacular hemorrhage?
A: A frequent cause is abnormal blood vessel growth under the retina (choroidal neovascularization), often associated with neovascular AMD. It can also occur with high myopia, trauma, polypoidal choroidal vasculopathy, or certain retinal vascular abnormalities. The cause is confirmed through exam findings and imaging.

Q: How is submacular hemorrhage diagnosed?
A: Diagnosis usually involves a dilated eye exam and retinal imaging. OCT is commonly used to show where the blood sits relative to retinal layers, and photography helps document baseline appearance. Angiography may be used when clinicians need more detail about abnormal blood vessels.

Q: Is it considered urgent?
A: Many clinicians treat new submacular hemorrhage as time-sensitive because the macula is involved and vision can change quickly. The exact urgency and next steps vary by clinician and case. Evaluation often focuses on confirming the diagnosis and identifying the source of bleeding.

Q: What treatments are used for submacular hemorrhage?
A: Treatment is directed at the underlying cause (such as therapies aimed at abnormal vessel activity) and, in select cases, at the blood itself (for example, displacement techniques). Not every case is treated the same way, and approaches differ depending on hemorrhage size, thickness, and diagnosis. Choices vary by clinician and case.

Q: How long does it take to recover vision?
A: Recovery time varies. Some hemorrhages partially clear over weeks to months, while others leave longer-lasting visual changes due to scarring or damage to the macula. Clinicians often use repeat OCT exams to understand how the retina is healing over time.

Q: Can submacular hemorrhage come back?
A: Recurrence is possible, especially when an underlying condition remains active or reactivates. Ongoing monitoring is commonly used to watch for new bleeding or fluid. The recurrence risk depends on the cause and overall retinal health.

Q: Can I drive or use screens if I have submacular hemorrhage?
A: Many people can use screens, but central blur or distortion may reduce reading speed and comfort. Driving safety depends on visual acuity, distortion, and local legal requirements, and it may change quickly with macular conditions. Clinicians typically discuss functional limitations in general terms based on measured vision.

Q: What does it cost to evaluate or treat submacular hemorrhage?
A: Costs vary widely based on the setting (clinic vs hospital), imaging performed, and whether injections or surgery are involved. Insurance coverage and regional pricing also make a major difference. A clinic or billing department can usually provide a case-specific estimate.